Trademark Overview
On Monday, March 3, 2025, a trademark application was filed for TRIFECTA CELL INFUSION with the United States Patent and Trademark Office. The USPTO has given the TRIFECTA CELL INFUSION trademark a serial number of 99064085. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 3, 2025. This trademark is owned by ImmunityBio, Inc.. The TRIFECTA CELL INFUSION trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical preparations and substances containing autologous or allogeneic cells for the treatment of human diseases in the nature of cancer, non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, and infectious diseases; biologics, namely, cell-derived preparations, cell therapies, monoclonal antibodies, cytokines, immune modulators, antibod...
